DocuGuru
Taylor & Francis

UroOncology Template

Write in a clean editor, then format for UroOncology in one click — DocuGuru applies the official Taylor & Francis template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

Use this template

About the UroOncology format

UroOncology is a peer-reviewed journal published by Taylor & Francis, covering Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Urinary and Genital Oncology Studies.

PublisherTaylor & Francis
Reference styleAuthor–year (Chicago, T&F)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." UroOncology 12 (3): 45–58.

Formats any DOI in UroOncology style. No sign-up.

Publishes research inBladder and Urothelial Cancer Treatments Prostate Cancer Treatment and Research Urinary and Genital Oncology Studies Prostate Cancer Diagnosis and Treatment Renal cell carcinoma treatment
ISSN1477-2795
h-index7
i10-index7
Total citations466
Top institutions publishing hereUniversitair Ziekenhuis Brussel
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in UroOncology per year

2
2001
34
2002
41
2003
31
2004

Citation impact of UroOncology by publication year

8
2001
31
2002
377
2003
50
2004

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in UroOncology

Case Report and Review

Carol Alliot, Patrice Rigaud, Philippe Derolland · 1 Jun 2003

The authors report the case of a 72-year-old man with a 10-year history of prostatism hospitalized for hematuria. Biopsies revealed a prostatic localization of lymphocytic lymphoma which staging workup was negative. Treatment only consisted of oral chemotherapy with chlorambucil. The patient remained asymptomatic 18 months after initial diagnosis. The literature regarding this rare condition is…

297 citations Cite SaveGo to paper →
Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients

K. Tomita, Adrie van Bokhoven, Cornelius F.J. Jansen et al. · 1 Sep 2003

Objectives: Functional E-cadherin adhesion complexes are necessary to maintain the normal differentiated phenotype in bladder epithelial cells and dysfunction of molecules in this complex is associated with an invasive phenotype. Moreover, loss of functioning of E-cadherin and/or α-catenin in cancer cells is associated with a poor prognosis for bladder cancer patients. Clearly, other adhesion molecules…

26 citations Cite SaveGo to paper →
Tolerability of Antiandrogens in the Treatment of Prostate Cancer

R. Fourcade, D. G. R. McLeod · 1 Mar 2004

This article presents and discusses data on the tolerability of the antiandrogens, both steroidal (cyproterone acetate; CPA) and non-steroidal (bicalutamide, flutamide, nilutamide), across all stages of hormone-responsive prostate cancer. Steroidal and non-steroidal antiandrogens have different endocrine effects and therefore different pharmacological side effects during monotherapy, with CPA generally resulting in loss of sexual interest and…

24 citations Cite SaveGo to paper →
Use of BCG in Immunotherapy of Superficial Bladder Cancer: Multicentric Investigation on Safety and Compliance

Giuseppe Morgia, Mario Falsaperla, Massimo Madonia et al. · 1 Jul 2003

Abstract Aim: Instillation-induced toxicity of BCG immunotherapy represent a real drawback. We decided to carry out a multicentric study to evaluate the tolerability of intravesical immunotherapy with BCG and in particular its effect on patient compliance and quality of life (QoL). Methods: A total of 92 patients were enrolled in the study, males and females…

14 citations Cite SaveGo to paper →

UroOncology template — frequently asked questions

How do I write a paper in the UroOncology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the UroOncology template. When you export, DocuGuru compiles the paper into the official Taylor & Francis format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does UroOncology use?
UroOncology uses Author–year (Chicago, T&F) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." UroOncology 12 (3): 45–58.
Do I need to know LaTeX to submit to UroOncology?
No. DocuGuru generates the interact LaTeX class and compiles the PDF for you in the background, so you get a Taylor & Francis-ready UroOncology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the UroOncology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the UroOncology format with correct headings, figures, tables, and author–year citations.
Who publishes UroOncology?
UroOncology is a multidisciplinary journal published by Taylor & Francis. DocuGuru's UroOncology template matches Taylor & Francis's official submission format.
Can I export a submission-ready UroOncology PDF?
Yes — DocuGuru produces a PDF built with the official UroOncology template (the interact class) that is ready to submit to Taylor & Francis, together with the matching LaTeX source files.
How much does the UroOncology template cost?
You can start writing in the UroOncology template for free. Exporting the final submission-ready UroOncology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the UroOncology template